This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John E. Piletz, PhD; Angelos Halaris, MD, PhD; Avtar Saran, MD; Matthew R. Marler

Arch Gen Psychiatry. 1991;48(9):813-820.

Abstract
• Platelet adrenergic receptor binding has been studied by several groups of investigators as a possible marker for depression and other psychiatric conditions. Although some of the findings have been discrepant, the results of the majority of studies that have used imidazoline compounds as ligands have confirmed elevated ₂—adrenergic receptor binding in depression. We have emphasized the advantages of obtaining platelet-purified plasma membranes and using tritiated para-aminoclonidine as the ligand of choice. By using "site-selective" concentrations of tritiated paraaminoclonidine, we have identified two high-affinity— binding sites of the platelet ₂—adrenergic receptor that appear to be upregulated in depression before treatment. Depressed patients were treated with desipramine hydrochloride for 6 to 8 weeks, and platelet binding was reassessed. Desipramine reduced binding to nearly normal levels at both site-selective concentrations of tritiated para-aminoclonidine. The concentrations of plasma catecholamines could play a role in the downregulation of binding at posttreatment. We discuss these findings in the context of platelet imidazoline-binding sites being a possible state-dependent marker for depression.

Author Affiliations
From the Departments of Psychiatry (Drs Piletz, Halaris, and Saran and Mr Marler), Neuroscience (Dr Piletz), and Pharmacology (Dr Halaris), Case Western Reserve University and the Departments of Psychiatry (Drs Piletz, Halaris, and Saran and Mr Marler), Neuroscience (Dr Piletz), and Pharmacology (Dr Halaris), Metro Health Medical Center, Cleveland, Ohio.

Footnotes
Accepted for publication April 15, 1991.

Reprint requests to Department of Psychiatry, Metro Health Medical Center, 3395 Scranton Rd, Cleveland, OH 44109 (Dr Piletz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunodetection and Quantitation of Imidazoline Receptor Proteins in Platelets of Patients With Major Depression and in Brains of Suicide Victims
Garcia-Sevilla et al.
Arch Gen Psychiatry 1996;53:803-810.
ABSTRACT